Literature DB >> 29680585

Functional and cognitive impairment, social functioning, frailty and adverse health outcomes in older patients with esophageal cancer, a systematic review.

Floor J van Deudekom1, Henk G Klop2, Henk H Hartgrink3, Jurjen J Boonstra4, Irene M Lips5, Marije Slingerland6, Simon P Mooijaart7.   

Abstract

BACKGROUND: Older patients with esophageal cancer are at high risk of adverse health outcomes, but the association of geriatric assessment with adverse health outcomes in these patients has not been systematically evaluated. The aim of this systematic review was to study the association of functional and cognitive impairment, social environment and frailty with adverse health outcomes in patients diagnosed with esophageal cancer.
METHODS: We searched Pubmed, Embase, Web of Science and Cochrane Library for original studies reporting on associations of functional or cognitive impairment, social environment and frailty with adverse outcomes (mortality, functional or cognitive decline, adverse events during treatment, prolonged length of hospitalization (LOS) and health related quality of life (HRQoL)) after follow-up in patients with esophageal cancer.
RESULTS: Of 1.391 identified citations, nineteen articles were included that reported on 53 associations. The median sample size of the included studies was 110 interquartile range (IQR 91-359). Geriatric conditions were prevalent: between 14 and 67% of the included participants were functionally impaired, around 42% had depressive symptoms and between 5 and 23% did not have a partner. In nineteen of 53 (36%) associations functional or cognitive impairment or frailty were significant associated with adverse health outcomes, but the studies were small. In four out of six (67%) associations with the largest sample size (n ≥ 359), functional impairment or social environment were significant associated with adverse health outcomes.
CONCLUSION: Functional and cognitive impairment, depression and social isolation are prevalent in patients with esophageal cancer, and associate with adverse health outcomes. Geriatric measurements may guide decision-making and customize treatments, but more large studies are needed to explore the clinical usability.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Esophageal cancer; Frailty; Functional impairment; Geriatric assessment; Older patients; Social status

Mesh:

Year:  2018        PMID: 29680585     DOI: 10.1016/j.jgo.2018.03.019

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  7 in total

1.  Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit.

Authors:  Catherine M Alfano; Deborah K Mayer; Smita Bhatia; Jane Maher; Jessica M Scott; Larissa Nekhlyudov; Janette K Merrill; Tara O Henderson
Journal:  CA Cancer J Clin       Date:  2019-03-08       Impact factor: 508.702

2.  Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach.

Authors:  Toshiki Terao; Takafumi Tsushima; Daisuke Miura; Kentaro Narita; Masami Takeuchi; Kosei Matsue
Journal:  EJHaem       Date:  2020-06-17

3.  Neoadjuvant chemoradiotherapy followed by resection for esophageal cancer: clinical outcomes with the 'CROSS-regimen' in daily practice.

Authors:  Marissa Cloos-V Balen; Edmée S H Portier; Marta Fiocco; Henk H Hartgrink; Alexandra M J Langers; Karen J Neelis; Irene M Lips; Femke P Peters; Marije Slingerland
Journal:  Dis Esophagus       Date:  2022-04-19       Impact factor: 2.822

4.  Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.

Authors:  Wen-Chi Chou; Cheng-Chou Lai; Chia-Yen Hung; Shun-Wen Hsueh; Kun-Yun Yeh; Chang-Hsien Lu; Ngan-Ming Tsang; Pei-Hung Chang; Ya-Wen Ho; Shih-Ying Chen; Yu-Ching Lin; Yu-Shin Hung
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

5.  Proton beam therapy is a safe and effective treatment in elderly patients with esophageal squamous cell carcinoma.

Authors:  Takashi Ono; Hitoshi Wada; Hitoshi Ishikawa; Hiroyasu Tamamura; Sunao Tokumaru
Journal:  Thorac Cancer       Date:  2020-06-08       Impact factor: 3.500

6.  Stakeholder-Identified Interventions to Address Cancer Survivors' Psychosocial Needs after Completing Treatment.

Authors:  Sarah Murnaghan; Cynthia Kendell; Jonathan Sussman; Geoffrey A Porter; Doris Howell; Eva Grunfeld; Robin Urquhart
Journal:  Curr Oncol       Date:  2021-11-25       Impact factor: 3.677

Review 7.  The Impact of Cognitive Impairment on Treatment Toxicity, Treatment Completion, and Survival among Older Adults Receiving Chemotherapy: A Systematic Review.

Authors:  Schroder Sattar; Kristen Haase; Isabel Tejero; Cara Bradley; Caroline Mariano; Heather Kilgour; Ridhi Verma; Eitan Amir; Shabbir Alibhai
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.